Rabbit Recombinant Monoclonal IL-2 antibody. Suitable for IP, WB, ICC/IF and reacts with Human, Recombinant full length protein - Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
IP | WB | ICC/IF | |
---|---|---|---|
Human | Tested | Tested | Tested |
Recombinant full length protein - Human | Not recommended | Tested | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/20 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant full length protein - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant full length protein - Human | Dilution info 1/1000 | Notes - |
Species Human | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant full length protein - Human | Dilution info - | Notes - |
Select an associated product type
Cytokine produced by activated CD4-positive helper T-cells and to a lesser extend activated CD8-positive T-cells and natural killer (NK) cells that plays pivotal roles in the immune response and tolerance (PubMed:6438535). Binds to a receptor complex composed of either the high-affinity trimeric IL-2R (IL2RA/CD25, IL2RB/CD122 and IL2RG/CD132) or the low-affinity dimeric IL-2R (IL2RB and IL2RG) (PubMed:16293754, PubMed:16477002). Interaction with the receptor leads to oligomerization and conformation changes in the IL-2R subunits resulting in downstream signaling starting with phosphorylation of JAK1 and JAK3 (PubMed:7973659). In turn, JAK1 and JAK3 phosphorylate the receptor to form a docking site leading to the phosphorylation of several substrates including STAT5 (PubMed:8580378). This process leads to activation of several pathways including STAT, phosphoinositide-3-kinase/PI3K and mitogen-activated protein kinase/MAPK pathways (PubMed:25142963). Functions as a T-cell growth factor and can increase NK-cell cytolytic activity as well (PubMed:6608729). Promotes strong proliferation of activated B-cells and subsequently immunoglobulin production (PubMed:6438535). Plays a pivotal role in regulating the adaptive immune system by controlling the survival and proliferation of regulatory T-cells, which are required for the maintenance of immune tolerance. Moreover, participates in the differentiation and homeostasis of effector T-cell subsets, including Th1, Th2, Th17 as well as memory CD8-positive T-cells.
Interleukin-2, IL-2, T-cell growth factor, TCGF, IL2
Rabbit Recombinant Monoclonal IL-2 antibody. Suitable for IP, WB, ICC/IF and reacts with Human, Recombinant full length protein - Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking/Dilution buffer: 5% NFDM/TBST.
Human IL2 active recombinant protein contains aa21-153.
All lanes: Western blot - Anti-IL-2 antibody [EPR20055] (ab207325) at 1/1000 dilution
All lanes: Human IL2 active recombinant protein at 0.01 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Predicted band size: 17 kDa
Observed band size: 14 kDa
Exposure time: 1min
Blocking/Dilution buffer: 5% NFDM/TBST.
The molecular weight observed is consistent with the literature, and the expression level can be induced in activated Jurkat cell. (PMID:10555752).
All lanes: Western blot - Anti-IL-2 antibody [EPR20055] (ab207325) at 1/5000 dilution
Lane 1: Untreated Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 10 µg
Lane 2: Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate treated with 40nM Phorbol-12-myristate-13-acetate, 2 μM A23187, and 300 ng/ml Brefeldin A (45 min delay) overnight at 10 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Predicted band size: 17 kDa
Observed band size: 14 kDa
Exposure time: 1min
IL2 was immunoprecipitated from 0.35 mg of Jurkat (Human T cell leukemia cell line from peripheral blood) treated with 40nM Phorbol-12-myristate-13-acetate, 2 μM A23187, and 300 ng/ml Brefeldin A (45 min delay) overnight lysate with ab207325 at 1/20 dilution. Western blot was performed from the immunoprecipitate using ab207325 at 1/200 dilution. VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366), was used for detection at 1/1000 dilution.
Lane 1: Jurkat treated with 40nM Phorbol-12-myristate-13-acetate, 2 μM A23187, and 300 ng/ml Brefeldin A (45 min delay) overnight lysate 10μg (Input).
Lane 2: ab207325 IP in Jurkat treated with 40nM Phorbol-12-myristate-13-acetate, 2 μM A23187, and 300 ng/ml Brefeldin A (45 min delay) overnight lysate.
Lane 3: Rabbit IgG, monoclonal [EPR25A] - Isotype Control (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab207325 in Jurkat treated with 40nM Phorbol-12-myristate-13-acetate, 2 μM A23187, and 300 ng/ml Brefeldin A (45 min delay) overnight lysate.
Blocking and dilution buffer and concentration: 5% NFDM/TBST.
Exposure time: 3 minutes.
All lanes: Immunoprecipitation - Anti-IL-2 antibody [EPR20055] (ab207325)
Predicted band size: 17 kDa
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized Jurkat (Human T cell leukemia cell line from peripheral blood) cells, untreated or treated with 40 nM Phorbol-12-myristate-13-acetate, 2 μM A23187, and 300 ng/ml Brefeldin A (45 min delay) overnight, labeling IL2 with ab207325 at 1/500 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077) secondary antibody at 1/1000 dilution (green).
Confocal image showing cytoplasmic staining on Jurkat cells. The signal is induced after treatment with 40 nM Phorbol-12-myristate-13-acetate, 2 μM A23187, and 300 ng/ml Brefeldin A (45 min delay) overnight.
The nuclear counter stain is DAPI (blue).
Tubulin is detected with (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195889) at 1/200 dilution (red).
Secondary antibody only controls on non treated and treated cells: Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077) at 1/1000 dilution.
Blocking and diluting buffer and concentration: 5% NFDM/TBST.
ab207325 is recommended to detect endogenous IL-2.
Anti-GAPDH antibody [EPR16891] - Loading Control ab181602 was used as GAPDH loading control.
Lanes 1 - 2: Western blot - Anti-IL-2 antibody [EPR2780] (Anti-IL-2 antibody [EPR2780] ab92381) at 1/5000 dilution
Lanes 1 - 2: Western blot - Anti-IL-2 antibody [EPR20055] (ab207325)
Lane 1: Untreated Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 10 µg
Lane 2: Jurkat cells treated with 40nM Phorbol-12-myristate-13-acetate,2 µM A23187 and 300 ng/ml Brefeldin A (45 min delay) overnight whole cell lysate at 10 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution
Predicted band size: 17 kDa
Observed band size: 14 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com